Avadel Pharmaceuticals

NASDAQ: AVDL · Real-Time Price · USD
13.69
0.19 (1.41%)
At close: Aug 15, 2025, 3:59 PM
13.55
-0.99%
After-hours: Aug 15, 2025, 04:39 PM EDT

Avadel Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
51.37M 31.17M 73.98M 50.71M
Short-Term Investments
22.41M 73.94M 22.52M 106.51M
Long-Term Investments
n/a n/a 1.23M -22.9M
Other Long-Term Assets
11.04M 579K -60.02M 33.78M
Receivables
34.1M 13.43M 2.32M 31.54M
Inventory
20.3M 10.38M n/a n/a
Other Current Assets
882K 913K 504K 550K
Total Current Assets
134.21M 134.2M 100.84M 192.49M
Property-Plant & Equipment
2.15M 13.08M 2.55M 2.94M
Goodwill & Intangibles
16.84M 16.84M 16.84M 16.84M
Total Long-Term Assets
30.03M 30.5M 31.94M 54.77M
Total Assets
164.24M 164.7M 132.78M 247.26M
Account Payables
7.33M 11.43M 7.89M 7.68M
Deferred Revenue
n/a n/a n/a 7.15M
Short-Term Debt
582K 934K 38.63M 900K
Other Current Liabilities
32.52M 11.59M 6.7M 2.62M
Total Current Liabilities
48.83M 36.85M 55.79M 21M
Long-Term Debt
n/a 32.76M 91.61M 142.4M
Other Long-Term Liabilities
40.43M 5.65M 5.74M 3.92M
Total Long-Term Liabilities
41.55M 40.1M 98.14M 148.02M
Total Liabilities
90.39M 76.96M 153.93M 169.02M
Total Debt
1.7M 35.38M 131.02M 145M
Common Stock
965K 898K 628K 586K
Retained Earnings
-794.33M -745.5M -585.22M -447.76M
Comprehensive Income
-24.58M -23.17M -26.34M -23.94M
Shareholders Equity
73.85M 87.74M -21.14M 78.24M
Total Investments
22.41M 73.94M 22.52M 106.51M